ArticleBMC cancer2015

Targeting mTOR/p70S6K/glycolysis signaling pathway restores glucocorticoid sensitivity to 4E-BP1 null Burkitt Lymphoma.

Ling Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.